C14H13AsClNO2, triclinic, P1¯$\overline{1}$ (no. 2), a = 7.7180(7) Å, b = 8.2190(7) Å, c = 11.9620(10) Å, α = 87.438(4)°, β = 73.450(4)°, γ = 72.167(4)°, V = 691.66(10) Å3, Z = 2, Rgt(F) = 0.0203, wRref(F2) = 0.0541, T = 200 K
The crystal structures of three isomers of (E)-4-chloro-N-{2-[2-(chlorobenzylidene)hydrazinyl]-2-oxo...
C38H58N10O6S4, monoclinic, P21 (no. 4), a = 11.9542(5) Å, b = 11.4057(5) Å, c = 17.2763(8) Å, β = 96...
The title molecular salts, C10H15N2+·C6H6ClN2O2−, (I), and C10H15N2+·C7H8ClN2O2−, (II), consist of 4...
C14H15AsClNOS, monoclinic, P21 (no. 4), a = 5.2852(2) Å, b = 13.3035(6) Å, c = 10.7522(5) Å, β = 90....
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
C3H9Cl2N, monoclinic, I2/a (no. 15), a = 8.7694(5) Å, b = 9.6963(6) Å, c = 14.8577(9) Å, β = 98.266(...
NOTE: Text or symbols not renderable in plain ASCII are indicated by [...]. Abstract is included i...
The compound 10-3'-chlorobutyl phenoxazine (A), crystallizes in the triclinic space group P (I) over...
The crystal structures in two solid phases, i.e. phase II stable between 146 and 253 K and phase IV ...
C7H3Cl3O, monoclinic, P21/c (no. 14), a = 12.0518(15) Å, b = 9.7403(11) Å, c = 6.9562(9) Å, β = 99.0...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C19H14ClNO2, monoclinic, P21/c (no. 14), a = 19.328(4) Å, b = 7.1086(12) Å, c = 11.627(2) Å, β = 99....
The crystal structure of (±)-2-[4-(4-chlorophenoxymethyl)phenoxy]propionic acid has been determined ...
The title compound, C15H13ClN4, crystallizes with two independent molecules (A and B) in the asymmet...
C15H11N3O2, triclinic, P1̄ (no. 2), a = 8.4680(5) Å, b = 9.7578(5) Å, c = 10.2101(6) Å, α = 104.578(...
The crystal structures of three isomers of (E)-4-chloro-N-{2-[2-(chlorobenzylidene)hydrazinyl]-2-oxo...
C38H58N10O6S4, monoclinic, P21 (no. 4), a = 11.9542(5) Å, b = 11.4057(5) Å, c = 17.2763(8) Å, β = 96...
The title molecular salts, C10H15N2+·C6H6ClN2O2−, (I), and C10H15N2+·C7H8ClN2O2−, (II), consist of 4...
C14H15AsClNOS, monoclinic, P21 (no. 4), a = 5.2852(2) Å, b = 13.3035(6) Å, c = 10.7522(5) Å, β = 90....
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
C3H9Cl2N, monoclinic, I2/a (no. 15), a = 8.7694(5) Å, b = 9.6963(6) Å, c = 14.8577(9) Å, β = 98.266(...
NOTE: Text or symbols not renderable in plain ASCII are indicated by [...]. Abstract is included i...
The compound 10-3'-chlorobutyl phenoxazine (A), crystallizes in the triclinic space group P (I) over...
The crystal structures in two solid phases, i.e. phase II stable between 146 and 253 K and phase IV ...
C7H3Cl3O, monoclinic, P21/c (no. 14), a = 12.0518(15) Å, b = 9.7403(11) Å, c = 6.9562(9) Å, β = 99.0...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C19H14ClNO2, monoclinic, P21/c (no. 14), a = 19.328(4) Å, b = 7.1086(12) Å, c = 11.627(2) Å, β = 99....
The crystal structure of (±)-2-[4-(4-chlorophenoxymethyl)phenoxy]propionic acid has been determined ...
The title compound, C15H13ClN4, crystallizes with two independent molecules (A and B) in the asymmet...
C15H11N3O2, triclinic, P1̄ (no. 2), a = 8.4680(5) Å, b = 9.7578(5) Å, c = 10.2101(6) Å, α = 104.578(...
The crystal structures of three isomers of (E)-4-chloro-N-{2-[2-(chlorobenzylidene)hydrazinyl]-2-oxo...
C38H58N10O6S4, monoclinic, P21 (no. 4), a = 11.9542(5) Å, b = 11.4057(5) Å, c = 17.2763(8) Å, β = 96...
The title molecular salts, C10H15N2+·C6H6ClN2O2−, (I), and C10H15N2+·C7H8ClN2O2−, (II), consist of 4...